NEA (New Enterprise Associates)

Tempus’ mission is to harness the power of data and AI to route every patient to a personalized therapeutic path, and in parallel, facilitate the discovery, development and delivery of optimal therapeutics

The Data + AI Company

Databricks helps data teams solve the world’s toughest problems by unifying all their data, analytics and AI on one Lakehouse platform

• Go to slide 1
• Go to slide 2
• Go to slide 3
• Go to slide 4
• Go to slide 5

Elion: The First Independent, Authoritative Digital Health Marketplace to Power Buying Decisions

The recent explosion of digital health has been catalyzed by several macro factors: the pandemic upended care delivery status quo, investments in… BY LILY HUANG, MOHAMAD MAKHZOUMI

Scott Sandell on The Twenty Minute VC

NEA Managing General Partner Scott Sandell joined Harry Stebbings on The Twenty Minute VC for a far-ranging conversation on the venture capital…

Snowplow: Unlocking Behavioral Data to Power the Next Chapter of Data Infrastructure

Enterprises began transitioning to the cloud nearly 20 years ago, and increased cloud adoption has also highlighted the importance of cloud data… BY ALEX SHARATA, TONY FLORENCE

Courtyard: Creating a World of Connected Collectibles

At NEA, we have been long-time believers in backing platforms that help bridge the gap between the digital and physical worlds in novel ways—an… BY ALEX SHARATA, JONATHAN GOLDEN

The Future of UX Personalization: Our Series A Investment in PixieBrix

Over the past decades, the internet has evolved to accommodate an ever-growing set of uses, from shopping to working to education Despite these… BY HILARIE KOPLOW-MCADAMS, HENRY MAGUN

The Future of Dating

The search for romantic connection is a universal human experience "For small creatures such as we, the vastness is bearable only through love "… BY DANIELLE LAY, HUNTER WORLAND

• Congratulations, Akouos! Akuous, developer of gene therapies for the treatment of inner ear conditions, to be acquired by Eli LIlly

Akuous, developer of gene therapies for the treatment of inner ear conditions, to be acquired by Eli LIlly

• Congratulations, Alex Sharata! We're proud to have tech Senior Associate Alex Sharata honored as an emerging VC worth watching! We're proud to have tech Senior Associate Alex Sharata honored as an emerging VC worth watching!